Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders
Authors:
- Gerd BeckerGBGerd Becker
- Hermann EinseleHEHermann Einsele
- Michael BambergMBMichael Bamberg
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 58 (3) , 235-246
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- LOW AND MEDIUM DOSE SPLEEN RADIATION THERAPY ARE ABLE TO INDUCE LONG-TERM RESPONSES IN SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTESBritish Journal of Haematology, 1998
- Splenic irradiation for hairy cell leukaemiaAustralasian Radiology, 1997
- Irradiation splénique dans les hémopathies myéloïdes: évaluation et toxicitéCancer/Radiothérapie, 1997
- Hairy Cell Leukemia VariantActa Haematologica, 1995
- SPLENIC IRRADIATION AS PRIMARY THERAPY FOR PKOLYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1990
- Splenic irradiation as primary therapy for prolymphocytic leukemiaAmerican Journal of Hematology, 1989
- Symptomatische Milzbestrahlung bei fortgeschrittener Osteomyelosklerose*DMW - Deutsche Medizinische Wochenschrift, 1986
- The Intrinsic Radiosensitivity of Lymphocytes in Chronic Lymphocytic Leukaemia, Quantitatively Determined Independently of Cell Death Rate FactorsInternational Journal of Radiation Biology, 1985
- Low-Dose-Rate Irradiation in the Treatment of Hairy Cell LeukemiaSouthern Medical Journal, 1983
- Splenic Irradiation in B-Prolymphocytic LeukaemiaBritish Journal of Haematology, 1981